Ms. Danese has over 20 years of strategic and marketing consulting in the pharmaceutical and healthcare industry and is a founding partner at Cadence. She brings a wide array of functional expertise, including strategic planning, product and franchise optimization, pipeline and in-line marketing, market research, forecasting, sales, sales operations, and regulatory affairs. This diverse skill set dovetails well with the recent culture of open innovation in healthcare, with recent engagements focusing on growth strategies for products, portfolios, and adjacencies; innovation in personalized medicine, diagnostics, health information technology, and hospital solutions; and commercial landscape and opportunity assessments in emerging ecosystems.
Previously, Ms. Danese was an Associate Director of Marketing at Amgen, with responsibility for a U.S. and global nephrology product launch, a Vice President at Migliara/Kaplan Associates (now TNS Healthcare), and a Regulatory Review Officer for the FDA’s Division of Drug Marketing, Advertising, and Communications with responsibility for drug labeling and other branding materials for neuropharmacology, oncology, respiratory, and anti-infectives drug products. She began her career as a sales & marketing representative for Eli Lilly and Company. Over this time, she has cultivated experience in a broad array of therapeutic areas including neurology, psychiatry gastroenterology, oncology, anti-infectives, respiratory, women’s health, and nephrology.
Ms. Danese earned a M.B.A. from the University of Virginia’s Darden School of Business and a B.S. in Chemistry from the University of Virginia.